HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect.

about

HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect.

Item

http://www.wikidata.org/entity/Q55430421

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect.

@en

HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect.

@nl

type

Item

label

HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect.

@en

HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect.

@nl

prefLabel

HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect.

@en

HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect.

@nl

P1476

HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect.

@en

P2093

Dan Kong

http://www.w3.org/2001/XMLSchema#string

Di Wu

http://www.w3.org/2001/XMLSchema#string

Duanyang Liu

http://www.w3.org/2001/XMLSchema#string

Jiang Zhu

http://www.w3.org/2001/XMLSchema#string

Jing Li

http://www.w3.org/2001/XMLSchema#string

Lei Gao

http://www.w3.org/2001/XMLSchema#string

Lei Zhang

http://www.w3.org/2001/XMLSchema#string

Weiwei Yang

http://www.w3.org/2001/XMLSchema#string

Xiaoming Jin

http://www.w3.org/2001/XMLSchema#string

Yu Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Management of drainage for malignant ascites in gynaecological cancer

A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors

The emerging role of HE4 in the evaluation of epithelial ovarian and endometrial carcinomas

Role of malignant ascites on human mesothelial cells and their gene expression profiles

Comparison of serum human epididymis protein 4 and carbohydrate antigen 125 as markers in ovarian cancer: A meta-analysis.

Inhibition of mesothelin-CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: Implications for cancer therapy.

Frequency of symptoms of ovarian cancer in women presenting to primary care clinics.

Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis.

HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm.

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients

P2888

s13048-018-0402-3

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13048-018-0402-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-06-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1104598918

http://www.w3.org/2001/XMLSchema#string

P698

29903044

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

chemotherapy

P932

6002981

http://www.w3.org/2001/XMLSchema#string